The Art of
Licensing 		The Art of
Development 		The Art of
Access 		The Art of
Manufacturing 		The Art of
Partnership
Home > The Art of Licensing > About Helsinn > News > 2010
2010
22.12.2010HELSINN BIREX PHARMACEUTICALS LIMITED HAS BEEN ASSIGNED CERTAIN INTERNATIONAL RIGHTS TO KLEAN-PREP® BY HELIX BIOPHARMA CORP.
01.09.2010HELSINN ANNOUNCES THE OFFICIAL OPENING OF ITS NEW R&D CENTRE OF EXCELLENCE IN DUBLIN
09.06.2010Helsinn Healthcare S.A. and Eisai Inc. Extend Relationship
08.07.2010HELSINN AND MUNDIPHARMA SIGN NEW CONTRACT FOR PALONOSETRON IN ASIAN COUNTRIES
26.04.2010HELSINN AND VIFOR PHARMA SIGN NEW CONTRACT FOR GELCLAIR IN SWITZERLAND
22.04.2010THE 5-HT3 RECEPTOR ANTAGONIST ALOXI® LAUNCHED IN JAPAN
02.02.2010Helsinn Chemical Operations is constantly becoming more environmentally friendly
02.11.2010HELSINN ANNOUNCES LICENSE AGREEMENT WITH SPECIALISED THERAPEUTICS FOR ALOXI® (PALONOSETRON) IN AUSTRALIA
20.01.2010ONCOLOGY: PALONOSETRON APPROVED IN JAPAN, SECOND PHARMACEUTICAL MARKET WORLDWIDE
09.11.2010HELSINN GRANT TO THE ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND (IOSI) - CONTRIBUTO HELSINN PER L’ISTITUTO ONCOLOGICO DELLA SVIZZERA ITALIANA (IOSI)
11.10.2010PALONOSETRON MORE EFFECTIVE THAN GRANISETRON IN CONTROLLING NAUSEA ACCORDING TO THE PROTECT STUDY
 
Home
Legal Statement
News
Contacts
Sitemap
Document Central
Jobs
Helsinn′s Board of Directors and Top Management
Links
Printer Friendly
Copyright © Helsinn Group - Legal Statement
Last Update: 16.05.2013
Free acces to Helsinn newsletter
Subscribe  or Unsubscribe
About Helsinn Our Products Our Partners